Top 5 Large-Cap Stocks for June 3

For the first quarter of fiscal 2009, the company reported that its revenue increased 7.9% year over year, beating the industry average of 3.1%. This appears to have led to FPL's 45.2% improvement in EPS, which is a continuation of a pattern of positive EPS growth over the past two years. We feel that this trend should continue, and the market expects an improvement from $4.07 to $4.23 this year. Net income also increased in the first quarter, rising 46.2% from $249 million to $364 million. Return on equity improved slightly when compared to the same quarter last year and can therefore be considered a modest strength for FPL Group. Although the company's stock price is down 15.86%, we do not feel that this should necessarily be interpreted as negative. The drop in price reflects, in part, the market's overall decline and is one factor that makes this stock an attractive investment at this time.

Based on its first quarter results, FPL Group raised its guidance for both fiscal 2009 and fiscal 2010. The company projects adjusted earnings for full year 2009 in the range of $4.20 to $4.40 per share and in the range of $4.65 to $5.05 per share for full year 2010. Although most measures we evaluated indicated that the company has had generally poor debt management, we feel that the strengths detailed above outweigh any potential weakness at this time.

Medco Health Solutions(MHS Quote) is one of the nation's largest pharmacy benefit managers, providing sophisticated traditional and specialty pharmacy benefit programs and services for clients, members of client-funded benefit plans, and individual patients. We have rated the company a buy since December 2008. This rating is supported by several positive factors, including its growth, notable return on equity, and good cash flow from operations.